Boston Scientific has enjoyed success in the cardiac device space, but it continues to look to gain market share elsewhere, ...
Boston Scientific has obtained an FDA green light for the latest version of its Watchman heart implant, designed to help lower the risk of stroke in patients with atrial fibrillation. Compared to its ...
Boston Scientific (NYSE: BSX) is scheduled to report its Q2 2024 results on Wednesday, July 24. We expect the company to report revenues and earnings in line with the consensus estimates. A rise in ...
The WATCHMAN FLX Pro team (pictured here) has successfully completed 159 WATCHMAN procedures, and will now only use the updated WATCHMAN FLX Pro Device moving forward. (Courtesy Photo) Medical Center ...
DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...
Medicare covers Watchman surgery if it is deemed medically necessary to reduce stroke risk in people with nonvalvular atrial fibrillation. Medicare parts A and B and Medicare Advantage may cover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results